发明名称 |
SERTRALINE ORAL CONCENTRATE |
摘要 |
The present invention provides an essentially nonaqueous, liquid pharmaceutical concentrate composition for oral administration containing sertraline or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The present invention also provides a use of this concentrate composition to prepare an aqueous solution of sertraline. In addition, the present invention provides a method of using this concentrate composition to treat or prevent a variety of diseases or conditions. Finally, the present invention provides the compound, (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine methanesulfonate.
|
申请公布号 |
WO0021521(A2) |
申请公布日期 |
2000.04.20 |
申请号 |
WO1999IB01571 |
申请日期 |
1999.09.22 |
申请人 |
PFIZER PRODUCTS INC.;HARPER, NANCY, JANE;RANADE, GAUTAM, RAMCHANDRA;WELCH, WILLARD, MCKOWAN |
发明人 |
HARPER, NANCY, JANE;RANADE, GAUTAM, RAMCHANDRA;WELCH, WILLARD, MCKOWAN |
分类号 |
A61K9/08;A61K9/00;A61K31/135;A61K47/02;A61K47/08;A61K47/10;A61K47/12;A61K47/18;A61K47/20;A61K47/22;A61K47/34;A61P1/14;A61P9/10;A61P25/18;A61P25/22;A61P25/24;A61P25/30;A61P35/00;(IPC1-7):A61K31/135 |
主分类号 |
A61K9/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|